Salta al contenuto principale

pantothenate kinase 2

L PANK2 gene provides instructions for making an enzyme called pantothenate kinase 2. This enzyme is active in specialized cellular structures called mitochondria, which are the cell's energy-producing centers. Within mitochondria, pantothenate kinase 2 regulates the formation of a molecule called coenzyme A. Coenzyme A is found in all living cells, where it is essential for the body's production of energy from carbohydrates, fats, and some protein building blocks (amino acids).

Scelte video per Genes
Video library

Normal function

L PANK2 gene provides instructions for making an enzyme called pantothenate kinase 2. This enzyme is active in specialized cellular structures called mitochondria, which are the cell's energy-producing centers. Within mitochondria, pantothenate kinase 2 regulates the formation of a molecule called coenzyme A. Coenzyme A is found in all living cells, where it is essential for the body's production of energy from carbohydrates, fats, and some protein building blocks (amino acids).

PANK2 is one of four human genes that provide instructions for making versions of pantothenate kinase. The functions of these different versions probably vary among tissue types and parts of the cell. The version produced by the PANK2 gene is active in cells throughout the body, including nerve cells in the brain.

Conditions referring to this gene or chromosome

Altri nomi

NBIA1

PANK2_HUMAN

pantothenate kinase 2 (Hallervorden-Spatz syndrome)

pantothenic acid kinase

Related patient information and medicines

Cancro alla bocca

Patient information leaflet

Cancro alla bocca

Epidermal growth factor receptor monoclonal antibody (EGFR mAb) is one form of targete... Cetuximab is an EGFR mAb. Tyrosine kinase inhibitors (TKIs) are another. Immunotherapy is treatment that aims to boost the body's own immune system to destroy the cancer cells. It is also sometimes called biological therapy: Recombinant interleukin (rIL-2) is.

Mielofibrosi

Patient information leaflet

Mielofibrosi

Mielofibrosi is a condition affecting the bone marrow ... The gene mutation that occurs in most people affected by myelofibrosis is a mutation in Janus Kinase 2 (JAK2). Dr Sarah Jarvis, December 2021 NICE guidance on drug treatments for myelofibrosis Fedratinib for treating disease-related splenomegaly or symptoms in myelofibrosis The National.

Distrofia muscolare

Patient information leaflet

Distrofia muscolare

Becker's muscular dy. Symptoms start in the teenage years or early 20s. The wea... Also, if a child has delayed motor milestones (as mentioned above), a doctor may advise testing for MD, even though the problem could be due to another cause. MD may be diagnosed using one or more of the following tests: A blood test Blood tests for creatine kinase.

Cancro primario al fegato

Patient information leaflet

Cancro primario al fegato

Some conditions which cause persistent inflammation of the gut increase the risk slightly of developing an uncommon type of primary liver cancer (called. Smoking There is some evidence that smoking Smoking can increase the risk. There are new medicines being developed for the treatment of liver cancer. For example, sorafenib is a type of medicine.

Disordini di accumulo di glicogeno

Patient information leaflet

Disordini di accumulo di glicogeno

Disordini di accumulo di glicogeno are a group of inherited diseases. They result from a problem with one of the proteins (known as enzymes) involved in the conversion of glucose to glycogen, or the breakdown of glycogen back into glucose. They mostly tend to affect your liver and muscles. Most are diagnosed in childhood. Symptoms include weakness,.

Artrite idiopatica giovanile

Patient information leaflet

Artrite idiopatica giovanile

As they are relatively new medicines, there are still studies being done to establish whether there are any long-term health risks from taking them. Options include: Etanercept Etanercept Tocilizumab Infliximab Abatacept Adalimumab Tofacitinib is another new drug. It belongs to a type of drug called JAK kinase inhibitors. It is sometimes used if.

Ulteriori letture e riferimenti

Storia dell'articolo

Le informazioni su questa pagina sono scritte e revisionate da clinici qualificati.
  • 18 Apr 2023 | Ultima versione
  • 1 Oct 2006 | Pubblicato originariamente

Partecipa alla conversazione

Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.

Avvertenza: The views expressed in the community do not represent medical advice. For any health concerns, consult your GP or healthcare provider.

Farmacia online, trattamenti e servizi sanitari

Accesso semplice a trattamenti affidabili e servizi sanitari online.

Common conditions

Get help with common conditions through the NHS, without a GP appointment.

Book your free Pharmacy First appointment

Iscriviti alla newsletter di Patient

La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.

Per favore, inserisci un indirizzo email valido

Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.